Development

CRISPR is used to shred the chromatin of p53-mutant cancer cells

development2026-06-13

Claim

The Innovative Genomics Institute used CRISPR-Cas12a2 to shred the chromatin of cancer cells carrying mutated p53, a flaw in nearly half of all cancers, while sparing healthy tissue.

Reported metric: ~50% of cancers

Reporting date: (not necessarily the event date)

Sources

Attribution and reporting linked by this record; links do not imply independent verification.

Knowledge graphopen in browser →

Reported in
Actor
Evidence for
Supersedes
Referenced by

Cite or correct this record

Suggest a correction — opens a GitHub draft for you to review and submit.